ABOUT US
Board of DirectorsHans T. Schambye
Christian Hansen
Florian Schönharting
Torsten Goesch
Wyle Solomon
Management
Scientific advisors
Investors
Hans T. Schambye, MD, PhD
Chairman
Hans Schambye joined ReceptIcon in 2006 as Chief Executive Officer. Dr. Schambye previously served as CEO of Gastrotech Pharma A/S, a Danish clinical stage biotech company. Before joining Gastrotech, Dr. Schambye was Director of Biology and Pharmacology and Head of Portfolio Management at Maxygen, a US biotech company. In 1999, Dr. Schambye co-founded ProFound Pharma A/S, a Danish biotech company, which was acquired by Maxygen in 2000. Previously, Dr. Schambye was a project manager at Novo Nordisk. Prior to this Dr. Schambye had a successful research career at Stanford University and Copenhagen University within the field of receptor biology. Dr. Schambye holds an MD from Odense University and a PhD in Medical Sciences from Copenhagen University.
Christian Hansen, PhD, MBA
Board member
Christian Hansen is co-founder and partner of Nordic Biotech. Read more.
Florian Schönharting, MSc
Board member
Florian Schönharting is co-founder and partner of Nordic Biotech. Read more.
Torsten Goesch, MD, PhD, MBA
Board member
Dr. Goesch is a director of BioScience Managers Limited (BML) which he joined in July 2002. Read more.
Wyle Solomon , MSc, MBA
Board member
Wyle Solomon is Vice President at Nordic Biotech. He came to Nordic Biotech in June 2007 . Read more.
